CORT

Corcept Therapeutics Incorporated

Contracts

Total Value

Stock Metrics

11.0%

Short % Float

6.4d to cover · Moderate squeeze

76.9%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

11.5% of float

89.0M sh

Public Float

11/100

Dilution Score

Low

24+ mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

11/100

LOW

Inst: 76.92% · Top: Blackrock Inc.

Biotech Analytics

Endocrinology

46.39

Squeeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk11

Clinical Trials100

Short Interest50